Printer Friendly
The Free Library
14,651,585 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Antimitotic agents topic

Complications and side effects subtopic

 

Articles

1-22 out of 22 article(s)
Title Author Type Date Words
Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption. Barrett-Lee, Peter Brief article Sep 1, 2009 288
New Data from Phase III SATURN Study Showed Tarceva Extended Survival in Patients with Advanced Non-Small Cell Lung Cancer When Used Immediately after Initial Chemotherapy. Clinical report Aug 1, 2009 1436
New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer. Jul 13, 2009 1202
Homeopathic meds may help relieve cancer therapy's side effects. Apr 15, 2009 331
Researchers learn why some platinum drugs damage ear tissue. McBride, Deborah Brief article Apr 1, 2009 291
Cytotoxic therapies to feel the sting of generics: cytotoxic therapy, or chemotherapy as it is commonly known, has been the cornerstone of cancer treatment for many years and involves the use of drugs that are toxic to all cells--including those that are perfectly healthy. While relatively effective, this leads to the unpleasant side-effects commonly associated with cytotoxic treatment, such as vomiting, nausea, alopecia and fatigue. Dick, Matthew Mar 1, 2009 790
Rituxan Data in Patients with Rheumatoid Arthritis to Be Presented at the American College of Rheumatology Annual Scientific Meeting. Clinical report Oct 27, 2008 1644
Clinical Trial Protocol Against Cancer Therapy Side Effects (Mucositis) Approved. Sep 3, 2008 335
Presidential campaign plans for universal health insurance: what they should cover--and won't Part 2. Cohen, Marcus A. Jul 1, 2008 3426
New Data Show Preemptive Treatment May Significantly Reduce Skin Toxicities in Patients Receiving Vectibix(R) (Panitumumab). Clinical report Jun 26, 2008 1970
Targeted therapies in breast cancer. Peck, Rahul; Kularatne, Bihani; O'Brien, Ciara Report Jun 1, 2008 3839
Did infiltrated injection site call for D/C of Taxol infusion? Tammelleo, A. David Case overview Feb 1, 2008 967
Chinese RU486 Manufacturer Distributed Tainted Anti-Cancer Drugs. Feb 1, 2008 475
Tarceva users suffer fewer toxic side effects. Nov 15, 2007 241
Manage skin toxicities associated with targeted therapies. Oestreicher, Pamela Nov 1, 2007 966
Occupational exposure to antineoplastic agents: What are the reproductive health risks? Lally, Robin M. Oct 1, 2007 667
Unfounded fears could limit prostate cancer treatment options. Strum, Stephen B. Jul 1, 2007 596
FDA Accepts and Grants Priority Review of ERBITUX(R) (Cetuximab) sBLA for Overall Survival in Patients with Advanced Colorectal Cancer. Jun 11, 2007 2198
Guidelines issued on managing skin reaction to new cancer drugs. Jun 4, 2007 716
Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology. Clinical report May 1, 2007 1422
Wellbeing and nutrition-related side effects in children undergoing chemotherapy. Garg, Manohar L. Dec 1, 2006 7767
Side effect revealed; heart risk found in leukemia drug. Jaffe, E. Jul 29, 2006 445

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles